Category Specific RSS

asx at1

Federal budget’s funding boost for HIV self-testing kit ups Atomo Diagnostics morale

By 2030, the Australian government aims to eliminate HIV transmission. An ambitious goal, but in line with the country’s declining…

1 year ago

Atomo’s HIV self-test kits head to low income countries with $970k Viatris order

Medical device company Atomo Diagnostics (ASX: AT1) has locked in purchase orders from Viatris Healthcare Pty Ltd amounting to approximately…

2 years ago

HIV, Covid and pregnancy tests drive Atomo revenue growth in Q2 FY24

Aussie medical device company Atomo Diagnostics (ASX: AT1), which provides rapid diagnostic tests, witnessed strong growth in revenue and margins…

2 years ago

Atomo Diagnostics to launch pregnancy tests as demand for Covid antigen tests peters out

As Covid fizzled out, the share price of medical device company Atomo Diagnostics (ASX: AT1) did, too, falling from $0.50…

3 years ago

Australian regulators approve Atomo’s rapid HIV diagnostic kit

Medtech company Atomo Diagnostics (ASX: AT1) has been granted regulatory approval in Australia for their patented AtomoRapid HIV (1&2) rapid…

5 years ago

Atomo’s rapid COVID-19 test approved by TGA for distribution

Australians will soon have access to a rapid COVID-19 test where results can be obtained in just 15 minutes from…

5 years ago